Professor of Medicine, Section of Hematology-Oncology
Chair, Committee on Clinical Pharmacology and Pharmacogenomics University of Chicago
Join Dr. Peter H. O'Donnell from University of Chicago for an engaging workshop on the transformative role of pharmacogenomics (PGx) in oncology. Explore how questions of clinical validity of PGx can be investigated through clinical trials focused on patient outcomes and the net-effect of personalized medicine in cancer treatment. This session will delve into the importance of PGx in optimizing therapeutic strategies, reducing adverse drug reactions, and improving patient care. Ideal for clinical labs and healthcare professionals, this workshop offers valuable insights into the future of oncology and the critical role of PGx in advancing precision medicine. Don't miss this opportunity to enhance your understanding and application of PGx in oncology.
